Table 2 Tumor budding studies in esophageal squamous cell carcinoma

From: Tumor budding as a standardized parameter in gastrointestinal carcinomas: more than just the colon

Study

Cohort

H&E/Keratin

Budding assessment

Low grade n(%)

High grade n(%)

Results

Roh et al. (2004)

Korea, n = 56

H&E

Area of maximal budding at ×200. Low grade (<5) and high grade (≥5)

22(39)

34(61)

3-year survival rates of 72 vs. 31% (p = 0.04)

Koike et al. (2008)

Japan, n = 136

H&E

Area of maximal budding at ×200. Low grade (<5) and high grade (≥5)

54(40)

82(60)

*3- and 5-year survival rates of 92/81 vs. 43/35% (p < 0.001)

*Independent prognostic factor by multivariate analysis

Nakanishi et al. (2011)

Japan, n = 82

AE1/AE3

Area of maximal budding at ×200. Low grade (<5) and high grade (≥5)

36(44)

46(56)

*Significant prognostic factor on univariate analysis (p = 0.0002)

*Not independent by multivariate analysis

Miyata et al. (2009)

Japan, Neoadjuvant, n = 71

H&E

Area of maximal budding at ×200. Low grade (<5) and high grade (≥5)

42(59)

29(41)

*Multivariate analysis: Significantly decreased overall survival in high-grade, independent prognostic factor (HR: 3.23, 1.61–6.49, p = 0.001)

*High-grade budding significantly higher in non-responders to neoadjuvant (67 vs. 25%, p = 0.001)

Teramoto et al. (2013)

Japan, pT1 tumors, n = 79

H&E

Area of maximal budding at ×200. Low grade (<3) and high grade (≥3)

50(63)

29(37)

*Multivariate analysis: Significant independent prognostic factor (HR 4.42)

*3-year survival significantly decreased in high grade (49 vs. 95%, p < 0.001)

Jesinghaus et al. (2017)

Germany, n = 135

H&E

Area of maximal budding, average count per hpf, over 10 hpf. Score 1 (0), 2 (1–14), 3 (≥15)

Score 1: 29(21)

Score 3:42(31)

*Tumor budding, and the proposed grading system, including budding, were significant prognostic factors (p = 0.001, p < 0.001)

Score 2: 64(48)

*Multivariate analysis: Grading sytem was independent of stage for overall survival (p < 0.001)